Status:
UNKNOWN
Characterization of Fatty Acid Composition of Triglycerides in Patients With Hypertriglyceridemia-induced Acute Pancreatitis
Lead Sponsor:
Sheba Medical Center
Conditions:
Hypertriglyceridemia
Eligibility:
All Genders
Phase:
NA
Brief Summary
) Finding a unique pattern in the triglyceride composition of patients with hypertriglyceridemia that increases the chances of getting pancreatitis and which can serve as a laboratory predictive tool ...
Detailed Description
The study will be conducted at the Sheba Medical Center Lipid Institute, number of participants: 10 healthy participants, 10 participants with hypertriglyceridemia without prior pancreatitis and 10 pa...
Eligibility Criteria
Inclusion
- 1\) Healthy participants - triglyceride levels\< 150 mg / dl over the past 5 years, with no diabetes or cardiovascular disease in the background.
- 2\) Participants with triglyceride levels 1000-5000 mg / dl without acute pancreatitis cases in the past.
- 3\) Participants with triglyceride levels 1000-5000 mg / dL and at least one case of acute pancreatitis in the last 5 years.
Exclusion
- A past pancreatitis event that occurred with measurement of triglyceride levels greater than 5000 mg / dL.
- Acute pancreatitis events in the past that occurred for a cause other than hypertriglyceridemia -
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04097990
Start Date
October 1 2019
End Date
October 30 2020
Last Update
July 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lipid center
Tel Litwinsky, Israel, 5265601